Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christel-Hermann Kamani"'
Autor:
Salvatore Annunziata, Roberto C. Delgado Bolton, Christel-Hermann Kamani, John O. Prior, Domenico Albano, Francesco Bertagna, Giorgio Treglia
Publikováno v:
Pharmaceuticals, Vol 13, Iss 11, p 377 (2020)
Some recent studies evaluated the role of fluorine-18 fluorodeoxyglucose (2-[18F]FDG) as a radiopharmaceutical for positron emission tomography/computed tomography (PET/CT) imaging in patients with Coronavirus Disease (COVID-19). This article aims to
Externí odkaz:
https://doaj.org/article/a1aff3d1978c4553a4922577fd0d8b00
Autor:
Christel Hermann Kamani, MD, Noor Sharrack, Ioannis Botis, MD, MSc, Hadar Schapira, Arka Das, MD, PhD, Peter Swoboda, Rob Van Der Geest, PhD, Sven Plein, MD, PhD, Erica Dall'Armellina, PhD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100623- (2024)
Externí odkaz:
https://doaj.org/article/7ec55600afb240e39d32c476e9a46941
Autor:
Christel Hermann Kamani, MD, Louise Brown, MD, PhD, Ioannis Botis, MD, MSc, Gaurav Gulsin, Sebastian Onciul, MD, David Broadbent, PhD, Alice Wood, MD, Christopher Saunderson, MD, Arka Das, MD, PhD, Nicholas Jex, MD, PhD, Amrit Chowdhary, PhD, Sharmaine Thirunavukarasu, PhD, Noor Sharrack, Kristopher Knott, PhD, Eylem Levelt, Peter Swoboda, Hui Xue, PhD, John P Greenwood, MD, PhD, James Moon, MD, Gerry McCann, Peter Kellman, PhD, Sven Plein, MD, PhD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100945- (2024)
Externí odkaz:
https://doaj.org/article/66d516e7fc0f489d98e0854a2c10b91f
Publikováno v:
Journal of Nuclear Cardiology. 29:2820-2822
Publikováno v:
HeartRhythm Case Reports
HeartRhythm case reports, vol. 7, no. 12, pp. 801-805
HeartRhythm case reports, vol. 7, no. 12, pp. 801-805
Publikováno v:
Diabetes. 56:2609-2615
OBJECTIVE—Peroxisome proliferator–activated receptor-γ (PPARγ) agonists (thiazolidinediones [TZDs]) are used for the treatment of diabetes. Bone marrow–derived endothelial progenitor cells (EPCs) improve vascular function and predict cardiova
Autor:
Philippe Meyer, Nicolas Vuilleumier, François Mach, Fabrizio Montecucco, Delphine S. Courvoisier, Christel Hermann Kamani, Baris Gencer
Publikováno v:
European Journal of Clinical Investigation, Vol. 45, No 10 (2015) pp. 1017-1024
European Journal of Clinical Investigation
European journal of clinical investigation
European Journal of Clinical Investigation
European journal of clinical investigation
OBJECTIVE Regular physical activity is recommended to lower low density lipoprotein cholesterol (LDL C) in a healthy population. Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) was shown to reduce (LDL C) levels however the impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ba95159bf32bb8f9463df2fe4ee9b9
https://archive-ouverte.unige.ch/unige:78915
https://archive-ouverte.unige.ch/unige:78915